Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/28/2905774/0/en/Orchard-Therapeutics-Celebrates-Global-Progress-toward-Advancing-Newborn-Screening-for-MLD-on-International-Neonatal-Screening-Day.html
https://www.fiercebiotech.com/biotech/pharming-group-uproots-angioedema-gene-therapy-collab-orchard
https://www.fiercebiotech.com/biotech/pharming-group-uproots-angioedema-gene-therapy-collab-orchard
https://www.globenewswire.com/news-release/2024/05/07/2876525/0/en/Orchard-Therapeutics-Announces-Multiple-Presentations-at-ASGCT-2024.html
https://www.globenewswire.com/news-release/2024/05/03/2875026/0/en/Orchard-Therapeutics-Co-founder-and-Chief-Executive-Officer-Dr-Bobby-Gaspar-Named-to-Inaugural-2024-TIME100-Health-List.html
https://www.fiercepharma.com/pharma/kyowa-kirins-orchard-sets-new-gene-therapy-price-tag-425m-steepest-any-drug-us
https://www.reuters.com/business/healthcare-pharmaceuticals/us-approves-first-gene-therapy-rare-genetic-disease-2024-03-18/
https://www.globenewswire.com/news-release/2024/03/18/2848132/0/en/Orchard-Therapeutics-Receives-FDA-Approval-of-Lenmeldy-atidarsagene-autotemcel-the-Only-Therapy-for-Eligible-Children-with-Early-onset-Metachromatic-Leukodystrophy-in-the-U-S.html
https://www.globenewswire.com//news-release/2024/02/05/2823377/0/en/Orchard-Therapeutics-Announces-First-Patient-Randomized-in-Registrational-Trial-of-OTL-203-for-MPS-I-Hurler-Syndrome.html
https://www.globenewswire.com//news-release/2024/01/25/2816563/0/en/Orchard-Therapeutics-Announces-Agreement-with-the-Beneluxa-Consortium-Enabling-Reimbursed-Access-to-Libmeldy.html